Strong 2006 Performance Provides Momentum For 2007
PRINCETON, N.J., Jan. 31 /PRNewswire/ -- Laureate Pharma, Inc., a full-
service bioprocessing company, is pleased to announce that it achieved
record growth in 2006 with fourteen new agreements signed and a business
backlog increase of more than 240% as compared to 2005. The company
increased its workforce more than 25%, is on track to complete its facility
expansion, and entered into key strategic alliances during the year. In
addition, Laureate Pharma formed a Scientific Advisory Board comprised of
well-respected industry leaders to help guide the company through its
evaluation of new services and emerging technologies. Collectively, all of
these factors position the company for continued growth and momentum for
2007 and beyond.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020723/LPHARMLOGO )
"We are extremely pleased with Laureate's overall performance in 2006,"
said Robert Broeze, President and Chief Executive Officer at Laureate
Pharma. "We have attracted an impressive list of clients and have made
significant progress toward our goal of being the preferred contract
manufacturing organization (CMO) for the biopharmaceutical industry. We
anticipate that our strong pipeline of projects, together with our
commitment to our clients, will generate continued success going forward."
"Laureate Pharma has established itself as an emerging leader in the
bioprocessing industry, with capabilities specifically focused on
monoclonal antibodies and recombinant proteins expressed in mammalian
cells," said James A. Datin, Executive Vice President and Managing
Director, Life Sciences Group, Safeguard Scientifics. "Laureate continues
to augment its organization and generate a solid channel of opportunities.
We are pleased with the company's progress in 2006 and look forward to
continued growth in 2007." Safeguard Scientifics acquired Laureate in
December 2004, providing the company with growth capital, operational and
management support to achieve its strategic plan.
About Laureate Pharma
Laureate Pharma, Inc. is a full-service biopharmaceutical development
and protein production company located in Princeton, New Jersey. Laureate
Pharma offers superior bioprocessing services that accelerate new products
from development through production. We provide a wide range of specialized
services from process design and development to full-scale cGMP production,
purification, aseptic filling, testing, validation, analytical services,
and regulatory support. Our business is focused on two active segments of
the biopharmaceutical industry: monoclonal antibodies and recombinant
protein products. For more information, contact Michael Cavanaugh, Vice
President Sales, Marketing, and Business Development at (609) 919-3400, or
info@laureatepharma.com or visit our web site at
http://www.laureatepharma.com.
About Safeguard Scientifics
Safeguard Scientifics, Inc. (NYSE: SFE) builds value in high-growth,
revenue-stage information technology and life sciences businesses.
Safeguard provides growth capital as well as a range of strategic,
operational and management resources to our partner companies. Safeguard
participates in expansion financings, corporate spinouts, management
buyouts, recapitalizations, industry consolidations and early-stage
financings. For more information about Safeguard and its strategy, visit
http://www.safeguard.com.
SOURCE Laureate Pharma, Inc.
back to top
Related links: http://www.laureatepharma.com http://www.safeguard.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20020723/LPHARMLOGO PRN Photo Desk photodesk@prnewswire.com
CONTACT: Michael Cavanaugh, Vice President Sales, Marketing, and Business Development, Laureate Pharma, Inc., +1-609-919-3400, or info@laureatepharma.com
|